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Abstract
Ginugu, Meghana Reddy, M.S., Department of Pharmacology and Toxicology, Wright State
University, 2021, Extracellular vesicles from UVB irradiated keratinocytes contain cyclobutane
pyrimidine dimers.
Ultraviolet (UV) radiation induces the formation of cyclobutane pyrimidine dimers
(CPDs) in genomic DNA, which are normally removed by nucleotide excision repair. However,
the fate of these adducts remain largely unexplored. Detection of these photoproducts in body
fluids could act as a predictor of UV exposure and enable a better understanding of the
pathogenesis of photosensitive skin diseases, such as lupus. Using cultured human keratinocytes
exposed to UVB radiation in vitro, ultracentrifugation of cell culture supernatants, and immunodot
blot analysis of isolated DNA, we have found that a small fraction of CPDs is released from cells
in a dose- and time-dependent manner in association with small extracellular vesicles (SEVs).
Furthermore, pharmacological manipulation of cell signaling pathways revealed that caspasedependent apoptotic signaling was critical to the release of SEVs containing CPDs. These results
show for the first time that CPDs are released from UVB-irradiated cells and co-purify with SEVs.
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Introduction:
1.1Statement of Problem:
DNA adducts are formed on DNA due to the exposure to environmental stressors like
Ultraviolet Radiation (UV). DNA excision repair mechanisms remove DNA adducts from
genomic DNA, but the fate of these adducts/fragments remains unexplored. Literature
shows that small extracellular vesicles (SEVs) contain many cellular contents including
DNA, microRNAs, and proteins, which could modulate the function and behavior of cells
that take up the SEVs. We have found CPDs outside of the cell in SEV fractions and believe
that SEVs may play a role in release of UV photoproduct containing DNA. Better
understanding how these UVB photoproducts arrive in this location may lead to scientific
and clinical advancements.

1.2 Significance:
Abnormal localization of DNA is associated with autoimmune disorders and other
inflammatory diseases (Safaei, Katano, et al., 2005; Safaei, Larson, et al., 2005).Thus,
studying the fate and localization of DNA containing UV photoproducts and other damage
has the potential to illuminate the pathogenesis of human diseases associated with UV
exposure. Previous reports have shown that DNA and damaged DNA have been found in
association with small extracellular vesicles (Lázaro-Ibáñez et al., 2019) We have found
that bulky adducts like CPDs are also found outside the cell associated with small
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extracellular vesicle fractions. Detection of photoproducts in association with SEVs could
act as a predictor of excessive UV exposure.

1.3 Statement of Purpose:
The main purpose of the study is to characterize CPD-DNA adducts outside of the cell. We
will analyze the CPD content released in different extracellular fractions. We will seek to
understand how it got there by pharmacological modulation of relevant pathways involved
in normal content export. Lastly, we aim to see if the CPD content is taken up by the
adjacent cells.

1.4 Hypothesis:
Our central hypothesis is that SEV associated damaged DNA is released from cells through
a regulated process. Moreover, we hypothesize that SEV associated CPDs can be taken up
by adjacent cells.

1.5 Rationale:
Research involves the study of UVB induced DNA damage and the formation of bulky
adducts. Normally, these adducts are repaired by excision pathways. However, CPDs have
been found in urine. It is still unknown how CPDs may be exported from the cells. In
preliminary studies, the Kemp Lab found CPDs in small extracellular vesicle fractions. We
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were able to suggest that SEV specific pathways are involved in adduct and damaged DNA
release. This could be studied through:
-

DNA analysis, adduct quantity and identity of DNA in EVs

-

EV analysis for protein markers and other damage markers

-

Study of pharmacological modulation of EV release pathways and DNA damage response
pathways.

1.6 Specific Aims:

Figure 1: Schematic representation of UVB induced release of extracellular DNA
containing CPDs
Specific aims include:
● AIM 1: Characterize the properties of CPD containing DNAs in cell culture media
from UVB irradiated cells.
● AIM 2: Determine how CPDs are released from UVB irradiated cells.
● AIM 3: Determine if CPDs can be taken up by other cells
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Literature Review:
2.1 Ultraviolet Radiation:
Ultraviolet radiation is an effective DNA damaging agent and acts as an important
environmental carcinogen which can lead to cancer(D’Orazio et al., 2013; Young, 2009).
Photoproducts like cyclobutane pyrimidine dimers (CPDs) and 6,4-photoproducts (6,4PPs) are formed after UV exposure. They are toxic and mutagenic to cells and get repaired
through NER. Failure to get repaired can result in increased risk of skin cancer. Example:
Xeroderma pigmentosum, Systemic Lupus Erythematosus.(Lee et al., 2016).
Ultra-violet radiation includes UVA (315-400nm), UVB (280-315nm), UVC(<280nm)
UVA is the lowest energy and mostly produces singlet oxygen species that damages DNA
by photosensitization, UVC is the highest energy, but is absorbed by ozone. UVB is the
predominant wavelength of UV light that is responsible for DNA damage, even though
<1% of UVB passes through atmosphere. UVB light is damaging because can cause
crosslinking of DNA base pairs to form Dewar isomers, cyclobutane pyrimidine dimers
(CPDs), or 6,4 photoproducts (6,4-PP) (Figure 2). These bases distort the DNA helix,
interfere with the transcription and translation, and can lead to mutations if not repaired.
(Rastogi et al., 2010a). CPDs and 6,4 photoproducts(6,4-PP) are repaired by nucleotide
excision repair (Rastogi et al., 2010b).

2.1.1 Cyclobutane Pyrimidine Dimers:
4

As mentioned before, UVB is the source of cyclobutene pyrimidine dimers. This reaction
is catalyzed by UVB and leads to the formation of a 4-membered structure between C5 and
C6 of neighboring bases. Usually, base damage is determined by flexibility as well as
nature and position of base (Kemp & Sancar, 2012b). These dimers are produced in a greater
yield than 6,4-pps or Dewar isomers (Reardon & Sancar, 2003). These are reported to be
predominant lesions due to the least efficacy by NER for the removal. (Choi et al., 2020).
This persistence makes them interesting to study. Moreover, CPDs can be easily detected
by a monoclonal CPD antibody (Hu et al., 2013).

Figure 2: UVB catalyzes the crosslinking of base pairs to form cyclobutane pyrimidine
dimers (CPD) or 6,4-photoproducts (6,4-PP). (Koning et al.)

5

2.1.2 Nucleotide Excision Repair:
CPD and photoproducts formed after UVB irradiation interfere with DNA metabolism and
normal cellular processes. These photoproducts or lesions on DNA can cause genomic
stress by impairing the replication and transcription processes. As a result, chances of
attaining mutagenesis, genomic instability, and risk of cancer increases. Efficient removal
of lesions by nucleotide excision repair (NER) is important for maintaining the genomic
integrity of the cell.
Nucleotide excision repair is the main mechanism to remove the DNA lesions including
CPDs. The process of NER involves the dual incision of phosphodiester bonds 5’ and 3’
to the lesion to generate a 24-to 32 nucleotide-long single-stranded oligonucleotide.
Simultaneously a ssDNA gap is created, and this is filled by generating a template strand
by DNA polymerase and restoration to initial state by DNA ligase (Figure 3).
Studies on DNA repair by nucleotide excision repair have identified many proteins that are
essential for the removal of photoproducts from genomic DNA in cells (Figure 3) (Choi et
al., 2020). However, there are many questions to be explored like the fate of the removed
oligonucleotides and the extent to which human diseases are associated with UV exposure
are dependent on NER.

6

Figure 3: Model of Nucleotide excision repair (Kemp et al).(Kemp & Sancar, 2012a).

2.1.3 Fate of Damaged Oligonucleotides:
Despite a detailed understanding of how CPDs are removed, an important question
remains: where do all the damaged oligonucleotides go after getting excised?(Kemp &
Sancar, 2012b). UV could produce hundreds and thousands of photoproducts in genome for

every 24 hours.(Baek et al., 2018a). The fate of these adducts (CPDs) after removal from
the genome remain unexplored. A hint that CPDs are exported from the cell was reported
by Baek et al in 2018. They found that UV photoproduct-containing DNAs was found in
the soluble fraction of cells exposed to high doses of UV radiation.(Baek et al., 2018a).
This was also caspase dependent, which may indicate that it is derived from an apoptotic
pathway of release. Moreover, we have also found evidence of CPDs outside of the cells
in extracellular vesicle fractions. It is likely that CPDs and other photoproducts are
7

exported from the cell in a regulated capacity. Therefore, we aim to investigate typical
pathways of cellular content release to try to understand the export of damaged DNA.

2.2 Extracellular Vesicles:
Extracellular vesicles (EVs) are lipid bilayer-enclosed particles released from cells and are
mediators of intercellular communication by transferring biological information between
cells. EVs are characterized primarily by size and mechanism of vesicle biogenesis. The
particle diameter ranges from 30 nm to 1 um (Figure 4) These vesicles have specialized
functions like intercellular signaling and waste management (Willms et al., 2018).
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Figure 4: Schematic showing relative extracellular vesicles size(A) mechanisms of
biogenesis(B) and exosome contents(C). Adapted from Moran et al 2018 (Morán & Cubero,
2018).

EVs can be classified into three different sub-groups by mechanism of biogenesis:
apoptotic bodies (AB), micro-vesicle particles (MVP) and exosomes. Apoptotic bodies are
cell membrane fragments and are generated during programmed cell death. Apoptotic
bodies are 1-5 µM in diameter and are released from cells undergoing apoptosis (Doyle &
Wang, 2019; Yuan Zhang et al., 2019). Additionally, Apoptotic bodies are known to contain

DNA and can perform key functions like horizontal transfer of DNA. Micro vesicles
particles or microparticles, are large EVs (LEVs) released by shedding or budding from
the plasma membrane. These are structures surrounded by a phospholipid bilayer(1001000nm) in diameter and are formed by regulated release by budding/blebbing of the
plasma membrane. Exosomes are the smallest vesicles and are 30-200 nm in diameter
(Tucher et al., 2018). Exosome biogenesis occurs through endo-lysosomal pathway
(Takano et al., 2020a) Exosomes form as intraluminal vesicles (ILVs) within
multivesicular bodies (MVBs). After formation, exosomes are released from cells upon
fusion of MVBs with the plasma membrane.
Some of the mechanisms by which exosomes may exert their biological function
on cells include: Direct contact between surface molecules of vesicles and cells,
endocytosis of vesicles, vesicle- cell membrane fusion, horizontal transfer of mRNA and
miRNA- (Riley & Tait, 2020a). Small extracellular vesicles are especially interesting due to
their pharmacological properties. SEVs have been demonstrated to cross the blood-brain
9

barrier (Malkin & Bratman, 2020). and may deliver a variety of contents, including DNA, to
adjacent cells (Pegtel & Gould, 2019a).

2.2.1 Exosome Formation:
Exosome biogenesis depends on the endosomal sorting complex required for transport
(ESCRT) machinery that is responsible for protein sorting and ILV formation. This
pathway is also impacted by the ceramide/sphingomyelin equilibrium pathway (Takano et
al., 2020a). Exosome release can be inhibited by used of nSMase2 inhibitor GW4869 or
promoted via mechanism by D609(Menck et al., 2017; Pegtel & Gould, 2019b). There is also
an increase in the number of exosomes released from tumor cells under conditions of
genomic and cellular stress like UVB irradiation and hypoxic conditions (Lázaro-Ibáñez et
al., 2019a; Takano et al., 2020b).
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Figure 5 Schematic Representation showing possible methods of DNA entry into the endolysosomal pathway prior to vesicle release. Pathway showing the biogenesis of exosomes.
Adapted from J. elzanowska et al 2020.(Elzanowska et al., 2020).

2.2.2 Vesicle Methods of Isolation:
Differential Centrifugation:
Differential Centrifugation, also called Differential Centrifugation (DUC), is widely used
to isolate exosomes from other extracellular vesicles. This includes many steps like lowspeed centrifugation and high-speed centrifugation. Initial steps isolate cell debris and
apoptotic bodies from the remainder. Centrifugation at higher speeds larger vesicles like
micro vesicle particles and precipitates exosomes. Often the SEV pellet is referred to as
exosomes but recent reports have demonstrated the heterogeneity of these populations. A
second method of validation is often needed to correlate SEV populations with exosomes.
This could be done by pharmacological modulation of EV biogenesis pathways to see
associated changes in content or a secondary type of isolation to further isolate subtypes of
SEVs. (Lázaro-Ibáñez et al., 2019c).

Density Gradient Fractionation:
Density gradient fractionation is an efficient process for purification of extracellular
vesicles based on the density. It utilizes a continuous gradient or a stepwise gradient-made
up of iodixanol or sucrose (Lázaro-Ibáñez et al., 2019b). This method gives the better
separation of extracellular vesicles in terms of purity and better resolution of EV markers
(Takahashi et al., 2017b).
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This method was utilized by Lazaro-Ibanez et al to confirm the presence of nuclear DNA
and DNA binding proteins in exosomes. After running an iodixanol density gradient
separation, they found that DNA and histones were enriched in high density EV fractions
along with histones, tetraspanins (CD9, CD63, CD81) were also present in high density
fractions, but were more concentrated in low density fractions. This suggests that both
populations were exosomal but perhaps two modes of EV content sorting or biogenesis are
occurring (Jeppesen et al., 2019).

2.2.3 SEV Content:
Small extracellular vesicles are released from all types of cells including healthy and
cancerous cells. They contain RNA, micro-RNA, and even DNA along with proteins like
histones (Dorayappan et al., 2018b). DNA is a well-documented content of SEVs.

2.3 DNA Contents of Small Extracellular Vesicles:
Studies based on the investigation of their content demonstrate that nuclear and
mitochondrial DNA could be associated with the small extracellular vesicles (LázaroIbáñez et al., 2019c). Studies report that nuclear DNA along with DNA binding proteins
can be found in high density fractions of SEVs purified by density gradient fractionation
(Dorayappan et al., 2018a; Schiller et al., 2008a). This was validated as genomic DNA in
EVs was found to contain chromatin along with histone. Localization of DNA was studied
and found to be surface oriented due to enzymatic degradation by DNase (Dorayappan et
al., 2018a; Guerra et al., 2019; Schiller et al., 2008b). Furthermore, degradation of surface
DNA lowered binding to fibronectin coated surfaces, which shows that the DNA present
on SEVs could participate in intracellular communication (Németh et al., 2017).
12

2.4 DNA Stress Response:
The DNA content in the SEVs enables them to may participate in intracellular
communication and DNA in SEVs may assist in immune cell activation to assist in tumor
clearance.
DNA could be taken up by other cells and this can activate anti-tumor immunity by cGASSTING pathway (Kitai et al., 2017a). Necrotic cells or tumor cells release exosomes
containing DNA, and due to the induction of Damage Associated Molecular Patterns
(DAMPs) in the DNA, immune cell activation occurs, resulting in cytokine production
(Kitai et al., 2017b). T-cells have been shown to release DNA containing exosomes which
are taken up by APCs (antigen presenting cells) that subsequently show activated viral
responses (Torralba et al., 2018a). The cGAS/STING pathway plays an important role in
many inflammatory and metabolic disorders (Takahashi et al., 2017b).
Conversely, if DNA is inhibited from being exported in SEVs it also causes a
stress response. It was shown that inhibiting the secretion of exosomes causes the activation
of DNA damage response by the activation of STING pathway that can be overcome by
expressing cytosolic DNase (Takahashi et al., 2017a). Thus, exosomes could help in the
maintenance of homeostasis by removing harmful DNA from cells (Takahashi et al.,
2017b).

2.5 DNA damage contents in SEVs:
DNA is a well-documented content of small extracellular vesicles. However, few studies
have considered the fact that many environmental and therapeutic DNA damaging agents
are expected to result in SEV DNA that contain bulky adducts and other forms of DNA
13

damage. A few groups have found that exosomal DNA contains damage. First, cisplatin
was detected in exosomes released from cisplatin-resistant ovarian cancer cell lines. This
was traced through golgi-endo-lysosomal pathway to SEV release using a fluorescent
cisplatin reagent (Safaei, Katano, et al., 2005b). However, due to the methods for detecting
this process, is unclear whether platinum, cisplatin or cisplatin-DNA adducts are exported
through this pathway. However, the detection of cisplatin in EVs and in the endo-lysosomal
pathways suggests that the other damaged DNA may also be exported through these
pathways (Sansone et al., 2017).
8-oxoguanine is one of the common DNA adducts in the DNA of hypoxic cells. DNA
exposed to UV contains 8-oxoguanine DNA adducts in addition to the other CPDs and 64PPs. Oxidized DNA was a demonstrated content of SEVs (Torralba et al., 2018a). When
delivered in SEVs, oxidized DNA leads to increased activation of cGAS/STING pathways
and increased production of cytokines. This was found to be due to the increased lifetime
of oxidized DNA due to its decreased rate of digestion by DNase like TREX (Gehrke et
al., 2013; Torralba et al., 2018a).
Both reports provide a template for investigation of UVB photoproduct contents in SEV
and the potential effects they might have generate in the cell. This enables in the detection
of DNA repair sensitivity to genomic stressors like UV.

2.6 UVB and SEV and DNA summary:
The full mechanism of loading of DNA content into EVs is not well understood.
Furthermore, there are only a few reports detecting damaged DNA in SEVs (Safaei,
Katano, et al., 2005b; Safaei, Larson, et al., 2005; Torralba et al., 2018a). We believe that
14

other DNA adducts like CPDs and 6,4photoproducts could also be exported in this SEV
pathway. Furthermore, it is likely that CPD content in EVs will be involved in the
stimulation of innate immune response pathways. Studying CPD release in extracellular
vesicles will help us to understand both the mechanism of DNA, loading into SEVs as well
as the mode of export of damaged DNA.
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Materials and Methods:

3.1 Cell Culture:
HaCaT cells were cultured in complete DMEM high glucose media supplemented with
10%FBS, streptomycin and penicillin. Cells are grown at 37℃, 5% CO2 in a water jacketed
incubator.

3.1.1 Cell Passaging:
After attaining confluency cells were split in the plate by washing one time with sterile 1X
PBS followed by the addition of 0.25% trypsin to lift off the cells from the plate. After 5
minutes trypsin was neutralized with the new media and cells were counted and seeded for
the experiment. 5*10^5 cells/ml will be the optimal seeding volume and confluency will
be attained in 2 days. Low passage cells are maintained by splitting for every 2 to 3 days
and cells of low passage were frozen using DMSO and stored in -80℃

3.1.2 Changing Media:
To change media, the old media was removed from the culture plate and was washed 3x
with PBS 1X. 10mL of fresh complete media was then added. Media change is done every
2-3 days between passaging.

3.1.3 Cell Counts:
Cells from different treatments are counted using this assay. 2ml of trypsin is added and
incubated for 2 to 5 minutes. Cell suspension is collected into a centrifuge tube(2ml). 10ul
16

of suspension and 10µl of trypan blue is added into new tube. Ten ul of the mixture is
analyzed with a countess cell counter by placing the countess slides. Cells are captured and
the count is recorded by taking the percentage of live and dead cells

3.1.4 Treatment Groups:
Cells were split into different plates based on the drug treatment groups. Treatment groups
typically included DMSO+UV, DMSO -UV, DRUG+UV, DRUG-UV. Ten µl of the drug
and DMSO are added to the respective plates and are incubated for 48h. Later the plates
labelled as +UV are irradiated at 500J/m2. Approximately 3.5µl of basal DMEM without
any supplements is added along with 3.5µl of drug/DMSO to the respective plates. These
plates are incubated for another 24 hours.

3.1.5 Drugs used:

Table 1: Table of drugs used to test CPD-DNA release mechanism

3.1.6 Exosome isolation by differential centrifugation:
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Cell supernatants were collected in 2ml centrifuge tubes from 10cm plate of different
treatments. They were placed in centrifuge and pelleted at 500 x g for 5min to remove cell
debris. The supernatant was collected into new 2ml tubes and centrifuged at 2.000 x g for
20 min and repeated at 20,000 x g for 70 min at 4ºC. At this stage pellet is retained and the
supernatant is transferred into ultra-centrifuge tubes. These tubes were centrifuged at
1,70,000 x g for 90 min. The pellet formed after this centrifugation is defined as the
exosome pellet expected and this is continued for different experiments.

Figure 6: Schematic representation of vesicle fractions through differential centrifugation

3.2 Nanoparticle Tracking Analysis:
Nanoparticle tracking is used to analyze the size and number of particles (size distribution
and concentration). In this process, the exosome pellet is resuspended in PBS and dilutions
of up to 100-fold are made with 1X filtered PBS. The samples are analyzed through Nano
Sight MS 300. Particles are captured and the particles/ml is multiplied with the respective
cell counts. Malvern analytical Nano Sight range of instrument utilizes Nano Particle
Tracking Analysis to characterize nanoparticles from 0.01-1µm in solution.

3.3 Immuno Dot-Blot Analysis:
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Genomic DNA was purified from UV-irradiated and non-irradiated cells using a Sigma
Gen Elute Mammalian Genomic DNA Miniprep Kit. Samples are applied on the
nitrocellulose membrane as dots and the blot is probed for CPD’s and ss DNA. The blot is
visualized using Bio-Rad Chemi Doc system software. Dots are quantified, CPD/ssDNA
signal was calculated, and statistical analysis was performed using Graph Pad Prism
software.
DNA extraction using Miniprep kit:
Following centrifugation, the exosome pellet is resuspended in 200µl of resuspension
solution and kept aside on a rocking shaker for about 40 min. 20µl of proteinase K and
RNase solution is added followed by 200µl of Lysis Buffer C. These tubes are incubated
for 10min at 70℃ and then DNA is purified over a spin column -the Sigma Gen Elute
Mammalian Genomic DNA Miniprep Kit protocol.
Sample Application:
Blocking:
Membrane was dried in conventional oven at 80c. Later the membrane was made wet using
1X TBST. Membrane was blocked using 5% milk in TBST on the rocking shaker for 25 to
30minutes.
Primary Antibody:
4 to 5 washings were done with 1X TBST and dilutions are varied based on the protein of
interest. 1:5000 and 1:10000 dilution is for CPD’s and SSDNA, respectively. The blots are
incubated overnight.
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Secondary Antibody:
Primary Antibody was removed by doing 5-minute washes with 1X TBST followed by
incubation with respective secondary antibodies (mouse, rabbit). Usually 1:5000 dilution
is taken and prepared with 5%milk for more specificity. The blot was incubated for 60
minutes. Then washings are done with 1X TBST at 5-minute intervals. The blot is
visualized under Bio-Rad Chemi Doc system software. Chemiluminescence was observed
at high resolution and appropriate settings were made (exposure of 1 sec to 600 sec).

3.4 Agarose Gel Electrophoresis:
This test is done to analyze the fragment size in the DNA fragments. Cells are pelleted and
are collected after the irradiation followed by incubation for 24 hours. The fractions are
obtained after respective centrifugations (genomic and SEV fractions). 0.8-2%of agarose
gel is prepared in gel chamber and 1µl of 10 mg/ml ethidium bromide is added and allowed
to set for about 4 hours. DNA extracted from the fractions is quantified based on the picogreen analysis. The amount to be loaded into the well is normalized to 10ul by using
loading buffer. Ladder of 1kbp (Thermo Fisher) is loaded into the wells for better
visualization of bands.
The samples can run on the gel for about an hour at 110-120V. The gel is removed from
the chamber and incubated in SYBR gold overnight. The gel is visualized under Bio-Rad
chemi doc system software. Chemiluminescence was observed at high resolution and
appropriate settings were made (exposure of 1 sec to 600 sec).
The fragments are seen on the gel and are analyzed based on the comparison with the
ladder, of which the size ranges up to 15000bp.
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3.5 Western Blot Analysis-SDS Page Electrophoresis:
This analysis was performed to confirm the EV markers from the DNA analysis of different
fractions obtained through centrifugation. UV-B irradiated or control conditioned media
from 10cm plates are taken and the samples are suspended in RIPA buffer. Protein was
measured using BSA assay and the amount of protein loaded was 5ug/sample in SDS page
buffer. This mixture was boiled for 5min at 95℃ and centrifuged at high speed for 5 min.
15ul of sample was added to each well of 15% agarose gel and electrophoresis was
conducted for 45min at 200V.
Membrane transfer:
Samples on the gel were transferred using 15 min transfer using high speed semidry
transfer buffer. Protein loading was measured using ponceau. Nitrocellulose membrane and
thick blot paper were soaked in a transfer buffer. A sandwich was prepared in the transfer
unit in the order of the blot paper, membrane, gel, and blot paper. Transfer was set at
25V/2.5amps for 15 minutes.
Blocking:
After the membrane transfer the membrane was added with 1X TBST and 0.5% ponceau
was added and kept on the rocking shaker for 2 to 5min to observe the protein bands on
membrane. Protein loading was measured using ponceau. Membrane was blocked using
5% milk in TBST on the rocking shaker for 25 to 30minutes.
Primary Antibody:
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4 to 5 washings were done with 1X TBST and dilutions are varied based on the protein of
interest. 1:10000 dilution is for Actin, 1 to 1000 dilutions were used for PCNA, H2AX,
Calreticulin, CD9, TSG101, PARP. The blots are incubated overnight.
Secondary Antibody:
Primary Antibody was removed by doing 5-minute washes with 1X TBST followed by
incubation with respective secondary antibodies (mouse, rabbit). Usually 1:5000 dilution
is taken and prepared with 5%milk for more specificity. The blot was incubated for 60
minutes. Then washings are done with 1X TBST at 5-minute intervals. The blot is
visualized under Bio-Rad Chemi-Doc system software. Chemiluminescence was observed
at high resolution and appropriate settings were made (exposure of 1 sec to 600 sec).

.
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Results:
4.1 Characterize the properties of CPD containing DNA in cell culture
media:
4.1.1 Distribution of CPDs in cell culture media by differential
ultracentrifugation:
Preliminary studies by Dr. Kemp identified CPD-containing DNA in the SEV- but not the
LEV containing fraction of cell culture media from HaCaT and KBM keratinocytes
exposed to UVB radiation (data not shown). To confirm these findings and to better
characterize the properties of CPDs that are released into the cell culture media of UVB
irradiated cells, differential centrifugation was performed to generate fractions
corresponding to cellular debris, apoptotic bodies, and exosome fraction.
HaCaT cells were irradiated with 500J/m

2.

- UV-B and then incubated for 24hours.

Differential centrifugations were performed as shown in Figure 7 at 500xg, 2000xg,
20000xg, 170000xg to obtain cellular debris, apoptotic bodies, micro vesicle particles,
exosomes, respectively. DNA was purified from the different fractions and then immuno
dot-blotting was performed to probe for the presence of DNA and CPDs. Antibodies for
CPDs are highly specific for CPDs and not 6,4-pps (Baek et al., 2018b). Additionally, we
used a ssDNA antibody, but we detect all the DNA because we fully denature the DNA
solutions prior to immune dot-blot. Genomic DNA of known concentrations were taken as
a reference on the blot.
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CPDs were observed in fractions corresponding to cellular debris, apoptotic bodies
(AB) and exosomes but are nearly absent in fractions containing the micro vesicle particles
and in the remaining supernatant.

Figure 7: Distribution of CPDs in cell culture medium by differential centrifugation.
Cells are subjected to differential centrifugations at 500xg, 2000xg, 20000xg, 170000xg.
A) representative immuno dot blot of DNA purified from different fractions and then
probed for CPDs and ssDNA. B) shows the CPD signal in each fraction was calculated as
a percentage of total CPD signal in all the summed fractions. The average (and SEM) signal
in each fraction is shown from three independent experiments.

4.1.2 Quantitation of CPDs in total media vs cells:
To determine what fraction of CPDs generated by UVB are found in cell culture media,
HaCaT cells were irradiated with 500J/m2 of UVB and were incubated for 0hr and 18hr
and then DNA was purified from both the cells and cell culture media (following
differential centrifugation as in figure 7. Immuno dot blot was performed to quantify the
CPD signaling remaining in the cells and in the different media fractions. As shown in
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figure 8, only 0.8% of the total CPDs generated by UVB exposure were found in the cell
culture media 18hr later. Approximately 43% of the CPDs remained unrepaired in the
genomic DNA of the cells on the plate 18hr later, and thus the majority of CPDs (56%)
that were removed from the genome over the 18hr incubation period were not retained in
either the cells or cell culture media. We presume that these are CPDs are in the form of
small DNAs that are not readily retained on the spin columns used in DNA purification.
Thus, we observed that CPD signal in the total media fraction is very negligible of the total
damage induced by UV-B exposure.

CPD content in Cells vs Total Media
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Figure 8: Quantitation of total CPDs in cellular genomic DNA and in the medium
18hr after the exposure to UV-B. Signals were compared to the CPD level in the cellular
genomic DNA immediately after UVB exposure (0hr). The “other” was calculated by
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subtracting the cellular CPD signal in the cells and total media at 18hr from 100%CPD
signal in the total media fraction and is therefore very small compared to the CPD signal
at 0 hr after UVB exposure.

4.2 Generation of CPDs after exposure to UVB radiation:
4.2.1 Release of CPDs in HaCaT cells after the exposure to UVB
radiation:
To determine how UVB dose impacts the release of CPDs in SEVs from UVB irradiated
HaCaT cells, HaCaT cells were plated in a 10cm dish in DMEM supplemented with 10%
FBS in presence of penicillin and streptomycin until they were 80% confluent. At this
stage, cells were rinsed 2x with PBS then irradiated with UVB at fluence rate of 5 J/m2/s
to achieve 125, 250, 500, or 1000 J/m2 UVB dose. DMEM (3.5 mL) in absence of serum
was returned to the dish and cells were cultured for 4 hours prior to collection of the
media. Media was pelleted using a slightly different differential centrifugation protocol
with steps at 2000xg for 15 min, 20,000xg for 70 minutes, and 170000 x g for 90 minutes.
DNA was purified from the exosome pellets and loaded into a dot blot apparatus described
in the materials and methods section. The data is a collection of 4 independent biological
replicates normalized to ssDNA signal and maximal signal at 1000J/m2. The results
showed that CPD abundance in SEV DNA was UV-B dose dependent, but that the DNA
content is not regulated by the UVB dose. Trypan blue staining was also performed in a
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separate set of experiments to count the number of live and dead cells. Interestingly, trypan
blue staining also shows a dose dependent increase in dead cells that appears to correlate
with the CPD signal
Based on the results, 500J/m2 was selected as dose for further experiments as it has shown
optimal CPD signal which correlated with the optimal % of live and dead cells by trypan
blue staining.
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Figure 9: Dose dependent kinetics of CPD release in HaCaT cells after UV exposure.
HaCaT cells were irradiated with 0-1000J/m2 UVB, conditioned media was collected 4
hours after irradiation, and SEVs were isolated using differential centrifugation with
differential centrifugation. Kit-Extracted EV DNA was dot blot with genomic standards
(500J/m2 UVB) and probed with ssDNA or CPD antibody. A) A representative dot-blot
shows a dose dependent increase in CPD signal, but not ssDNA signal. B) Significant
increases over signal at

0J/m 2 are seen in CPD/ssDNA, CPD seen at 250, 500, and 1000

J/m2 UVB as measured by Dunnet's multiple comparison test. C) Trypan blue staining for
cells collected at different doses of UVB exposure. (*, (p<0.05), **, (0.01<p≤0.01, ***
(0.001<p≤0.001), **** (0.0001<p)).

4.2.2 Kinetics of CPD release:
To determine the kinetics of CPD release in SEVs of human keratinocytes, HaCaT cells
were exposed to 500 J/m2 and then incubated for 0, 2, 4, 6 or 24hr. Immunodot blot analysis
was performed with DNA purified from SEV fraction as seen in (Figure 10 C). Resulting
data is a collection of 3 independent biological replicates. CPD/ssDNA signal is
significantly higher in UV+ than in UV- samples at 6hours and later. This experiment
makes sense because it was reported that the release of CPDs occur after 6hours. Repair of
CPDs occur at earlier time points whereas large DNA fragments occur at higher time
points. This was believed to happen due apoptotic laddering fragmentation resulting in
larger DNA fragments. These fragments were reported in the soluble fraction of
photoproduct containing DNAs that follow caspase regulated pathway (Baek et al., 2018b).
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To confirm that this process is correlated with SEV release, we also
analyzed particle counts in the SEV fraction for 2 of the 4 replicates. The number of
particles/plates appear to correlate with CPD release and numbers of dead cells. (Figure
10 A, B). Furthermore, we once again see that CPD release is also correlated with cell
viability (N=1) (Figure 10 B).

Figure 10: Time dependent kinetics of CPDs in HaCaT cells after UV exposure.
HaCaT cells were irradiated with 500J/m2 UVB, and then, conditioned media was collected
at various time points (0hr, 2 hr, 6hr, 24hr) after irradiation. SEVs were isolated
using differential centrifugation and DNA was dot blotted with genomic standards (500J/m
2

UVB). Blots were probed with ssDNA or CPD antibody. C). A representative dot-blot

shows a dose dependent increase in CPD signal, but not ssDNA signal. A, B) Compiled
NTA and trypan blue assay shows significant increase in CPD/SSDNA signal and %of
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dead cells in UV+ samples compared to UV- samples, respectively. Significance is
measured by 1 way ANOVA. D) Significant increases are seen in CPD/ssDNA seen
at UV+ samples compared to UV- samples as measured by 2-way ANOVA using Dunnet's
multiple comparison test. (*, (p<0.05), **, (0.01<p≤0.01, *** (0.001<p≤0.001), ****
(0.0001<p)).

4.3 Location of CPDs in or on exosomes:
Studies have reported that DNA may be present in the lumen (Kahlert et al., 2014;
Takahashi et al., 2017a; Torralba et al., 2018b). or even on the surface of SEVs (Gehrke et
al., 2013; Kitai et al., 2017a). To determine whether CPD containing DNA that we observe
associating with SEV is on the surface of EVs or inside EVs. We isolated SEVs 24hr after
exposure of HaCaT cells to 500J/m2UVB and then treated the SEVs with DNase. As shown
in Figure 11, the results showed that the treatment eliminated the detection of CPDs and
DNA, which indicates that the CPD-containing DNA is on the surface of the SEVs and
hence are readily susceptible to digestion by DNase.
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Figure 11: DNase treatment on EV’s show that DNA is surface oriented: SEVs isolated
from UVB treated HaCaT cells were treated with DNase I in 4 technical replicates and the
DNA isolated from each with a DNA isolation kit. A significant reduction in DNA and
CPDs after DNase I treatment (paired, 1 sided t-test, p<0.01) suggests that DNA is surface
associated. (*, (p<0.05), **, (0.01<p≤0.01, *** (0.001<p≤0.001), **** (0.0001<p)).

4.4 Size Range of DNA fragments in exosome fraction:
To determine the length of the DNA fragments in the SEV, DNA was purified from SEVs
and from genomic DNA of HaCaT cells following exposure to 500J/m

2

of UV-B.

Fragment analysis was done through agarose gel electrophoresis. Genomic DNA and EV
DNA fractions concentration were determined by the Pico green analysis so that equal
amounts of DNA were loaded into each well. As shown in Figure 12 We observed a large
range of length of DNA (200-10000bp) in the DNA from SEVs from both the non- and
UVB-irradiated cells. However, the average length of the SEV DNA from the irradiated
cells was slightly longer than from the non-irradiated cells. This may be due to the presence
of lesion in the DNA that inhibit degradation of UVB irradiated DNA by cellular nucleases
(Kemp et al., 2015). In the genomic DNA the trend is the opposite: DNA tail size increases
with UVB+ treatment. However, this is the expected result as one can expect more DNA
laddering from apoptotic signaling in UVB treated cells (Roy & Nicholson, 2000). Note,
here that DNA size could not be measured as it is above the highest ladder size. Regardless,
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the large size of the SEV-associated DNA suggests that it could be associated with histones
and other nuclear-derived chromatin proteins.

Figure 12: Gel electrophoresis of DNA fragments in Exosome fractions-DNA was
purified from SEVs (EV) from cellular genomic DNA(G) from HaCaT cells exposed (or
not) to UVB radiation. Genomic DNA and EV DNA fractions concentration was
determined using Pico green fluorescence. DNAs were analyzed by Agarose gel
electrophoresis wit 1kb+ ladder (Thermo Fischer Scientific) was used as a DNA size
marker.

4.5 Western blot showing histone H3 and H2AX in exosome fraction after
UVB exposure:
Because the large size of the SEV-associated DNA (Figure 12) suggested that it
may be associated with other chromatin-associated proteins. Western blot analysis was
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performed for histones (H2AX-p and H3) and other DNA bound proteins like PCNA.
HaCaT cells were sham- or UVB (500 J/m2)-irradiated, incubated for 24 hours, and then
differential centrifugation was carried out with the cell culture media. Equivalent amounts
of protein (5 µg) were electrophoresed on an SDS gel and examined by western blotting
from Figure 13,14) we can observe that PCNA is enriched in the different fractions after
UVB exposure. Other proteins, including phosphorylated H2AX and histone H3
specifically enriched in the SEV fraction compared to the LEV fraction got upregulated in
SEV fraction exposed to UVB compared to UV- samples.
The western blot for DNA related proteins was paired with an analysis for proteins
associated with vesicle fractions. Exosome markers were tested and show increased
content in SEV fractions. Tetraspanins, CD63, CD81, and ESCRT related protein TSG101
were enriched in UV+ and UV- SEV fractions over levels seen in LEVs or apoptotic
bodies. Interestingly, CD9 was enriched only in SEV-UV fractions and barely detected in
SEV+UV fractions. TSG101 and CD81 are also slightly reduced in SEV-UV fractions.
This may indicate that a secondary pathway contributes more to protein content in SEV
fractions after UVB treatment. In terms of other vesicle markers, it is unlikely that these
are traditional MVPs or Apoptotic bodies since both ARF6 and Calreticulin are barely
visible in SEV fraction. Interestingly, AB marker, calreticulin, is upregulated in AB and
LEV fractions that were derived from UVB+ keratinocytes.
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Figure 13: Western blot showing DNA associated proteins in vesicle fractions. Western
blots were of 15% SDS PAGE gel run either reducing or non-reducing conditions were
probed for different EV (A) or DNA (B) associated proteins. All samples were obtained in
the same experiment: vesicle fractions were collected 24 hr after 500J/m2 UVB or sham
treatment and fractions separated through differential ultra-centrifugation protocol (Figure
6). Proteins were loaded at 5 ug protein/lane. Ponceau red was used as a protein loading
control and shows that some differences in protein content are seen.
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4.6 Determine how CPDs are released from UVB
irradiated cells:
According to Aim 2, we next examined the mechanism by which CPDs are
released from UVB-irradiated HaCaT cells using different pharmacological
compounds that target cell signaling pathways relevant to UVB exposure and exosome
processing.

4.6.1 Effect of exosome stimulator D609 on the release of CPDs in the
exosome fraction of UVB irradiated cells:
CPD release through the EV dependent pathway was investigated with the use
of exosome stimulator D609. D609 treatment is supposed to stimulate the exosomes
through inhibition of sphingomyelin synthase2 (SMS2, Figure 14) (Takano et al.,
2020b; Villarroya-Beltri et al., 2014a).

Figure 14: Schematic of sphingomyelin equilibrium pathway. D609 stimulates
exosome formation through increased ceramide levels (a negative curvature inducing
lipid) via inhibition of SMS2. GW4869 reduces exosome biogenesis by inhibiting the
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formation of ceramide by nSMase2. Adapted from Villaroya-Beltri et al 2015
(Villarroya-Beltri et al., 2014b).

As shown in Figure 15(A, B), D609 did not significantly alter CPD release.
In both DMSO and D609 treatment groups the fold change in CPD content over UVtreatments is the same and shows the same significance. Interestingly, the ssDNA
DMSO treatment also shows a significant increase in DNA content with UVB
treatment, which is partially abrogated in D609 treatment group (Figure 15B). No
other changes were seen in DNA content between DMSO and D609 treatment groups
which implies that this pathway may not be regulated by this drug.
To confirm that the drug was indeed working, NTA was also performed to
confirm D609 dependent stimulation SEV release. We observed that D609 partially
suppressed the stimulation of SEV release that is normally stimulated by UVB
exposure (Figure 15 C, D). This is the opposite of what is expected with D609
treatment which is supposed to stimulate the exosomes through ESCRT mediated
pathway These results indicated that a different mechanism of SEV release other than
through tetraspanin regulated pathway may play a dominant role after UVB treatment.
Alternatively, the particle counts are highly cell count dependent. Perhaps
normalization to total cell counts may result in a significant change in SEV release.
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Figure 15: D609 did not alter the release of CPD’s invitro by stimulating the release
of exosomes. HaCaT cells are treated either with vehicle (DMSO) or 10uM D609, a known
exosome stimulator, incubated for 48h and post irradiation with UV-B of 500 J/m2.DNA
was extracted using DNA isolation kit and EV isolation was performed through differential
centrifugation. A) Representative dot blot showing CPDs and ssDNA B) NTA was
performed. Resulting data is a collection of 2 independent biological replicate experiments
with duplicate samples normalized to DMSO+UV. Groups were compared using One-way
ANOVA and Tukey’s Post-hoc test. Differences in samples were considered significant if
alpha is less than 0.05. C) CPD release in D609 were analyzed and normalized to
DMSO+UV through dot blot. Data depicted as relative CPD signal with DNA. Resulting
data is a collection of 4 replicates and Groups were compared using One way ANOVA and
Tukey’s post hoc test. (*, (p<0.05), **, (0.01<p≤0.01, *** (0.001<p≤0.001), ****
(0.0001<p)).
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4.6.2 Effect of exosome inhibitor GW 4869 on the release of CPDs:
CPD release through the EV dependent pathway was further investigated with the use of
exosome inhibitor GW 4869 which inhibits ceramide production through inhibition of
nSMase activity (Figure 14). HaCaT Cells were pre-treated with DMSO or 5 µM or 20
µM GW 4869 for 48h. The relative CPD/ssDNA signal in the SEVs was reduced in the
drug +UVB group when compared to sham group (DMSO+UV), but only when treated
with 20µM (Figure 16C). Raw CPD was increased in some experiments by GW 4869 at
5µM. ssDNA follows the typical pattern of increased ssDNA content in UVB+ treated SEV
group over UVB- controls. The application of GW4869 did not significantly change this
result.
NTA was performed to determine exosome concentration and validate that
GW4869 was showing the expected decrease in particle count. Though we expect to find
GW4869 would decrease SEV release, we instead found increased particle counts with
UVB irradiated cells treated with GW4869 at 5µM. The particle counts were slightly
lowered by increasing the dose from 5 µM to 20 µM, but it still is not significantly lower
than the DMSO+UVB control. No treatment with UVB in both DMSO and GW groups
also shows no significant changes between treatment groups. Unfortunately, we do not
know if the GW4869 drug did not work under our conditions, or if there is an alternative
driving force.
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Figure 16: Effect of GW 4869 on CPD and SEV release in UVB irradiated HaCaT cells.
HaCaT cells are treated either with vehicle (DMSO) or 5 µM GW4869, a known exosome
inhibitor, incubated for 48h and post irradiation with UV-B of 500J/m2 DNA was extracted
using DNA isolation kit and EV isolation was performed through differential centrifugation. A)
CPD release in GW4869 were analyzed by dot blot and normalized to DMSO+UV signal. B)
Data depicted as relative CPD signal with DNA through quantification. C) NTA was even
performed Exosome pellet was resuspended in 1XPBS and dilutions were made to 100X. The
samples are analyzed through Nano sight 300. Particles are captured and the particles/ml is
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multiplied with the respective cell counts. Malvern analytical Nano Sight range of instrument
utilizes Nano Particle Tracking Analysis to characterize nanoparticles from 0.01-1um in
solution. Resulting data is a collection of 3 independent biological replicate experiments with
duplicate samples normalized to ssDNA signal and SE is calculated. Groups were compared
using paired 1-way t-test. (*, (p<0.05), **, (0.01<p≤0.01, *** (0.001<p≤0.001), ****
(0.0001<p).

4.6.3 Effect of lysosomal inhibitors on the release of CPDs:
Lysosomal inhibitors such as hydroxychloroquine and Bafilomycin A1 have been
demonstrated to affect exosome particle release (Hikita et al., 2018). This occurs due to
decreased shuttling of endosomal content through lysosomal pathways which forces more
content to be released as exosomes. HQ acts to inhibit lysosome degradation by inhibiting
autophagosome fusion. Bafilomycin is a V-ATPase inhibitor which acts by impairing
lysosomal acidification and fusion of lysosomes. Both should increase particle counts over
controls and should increase CPD content in SEVs if CPDs follow endo-lysosomal
pathways and any content is typically degraded in the lysosome. Few studies even reported
that NTA results of Bafilomycin A1 had shown a significant increase in exosome
production (Ortega et al., 2019).
CPD release through the EV dependent pathway was first investigated with the
use of hydroxy chloroquine. Cells were pre-treated with vehicle or 10µM Hydroxy
chloroquine for 48h and then exposed to UVB for the isolation of SEVs. CPD/ssDNA
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signal is higher in UV+ than in UV- samples. There is no significant decrease observed in
chloroquine treated with UVB when compared to vehicle UV+ group.

Figure 17: Effect of hydroxy chloroquine on CPD release in HaCaT cells. A) shows a
representative dot blot of hydroxy chloroquine and water(vehicle) probed for CPD and
ssDNA antibodies. B) represents CPD, ssDNA and CPD/ssDNA signal of chloroquine and
water(vehicle) normalized to water (vehicle) +UV. Significance was analyzed using 1-way
ANOVA and Tukey’s multiple comparison test in GraphPad Prism 8. (*, (p<0.05), **,
(0.01<p≤0.01, *** (0.001<p≤0.001), **** (0.0001<p)).
Chloroquine acts as a lysomotropic agent that which interfere with the endosomal
maturation and prevents the fusion of late endosomes and lysosomes by altering the pH.
ILV formation is significant at lower pH and upon degradation by lysosomes results in the
release of exosomes(Eitan et al., 2016; Ortega et al., 2019). CPD release through the EV
dependent pathway was further investigated with the use of BafilomycinA1. Cells were
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pre-treated with DMSO (0.1%) or BafilomycinA1 (100nM, 0.1%DMSO) for 24 h and then
exposed to 500J/m2 UVB. SEVs were collected 24 hours later from 3.5mL media that was
not supplemented with FBS or additional BafA1. Unlike the CQ data, NTA was run. A
significant increase in NTA particle counts was measured when BafA1 was applied.
However, the UVB+ treatment group did not show further increase in particle counts.
Perhaps the released number of particles/cells is saturated by the bafilomycin treatment.
For the DNA signal, as typically observed, ssDNA signal is not significantly affected, and
CPD/ssDNA signal is higher in UV+ than in UV- samples. The significant change is only
seen for 1 treatment group. This is a factor of normalizing the data. Depending on which
group is used for normalization, that group shows significant increases in CPD signal and
CPD/ssDNA signal. It is likely that bafilomycin does not alter CPD or DNA content
release.
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Figure 18: Effect of Bafilomycin A1 on CPD and SEV release in HaCaT cells. HaCaT
Cells were treated with Bafilomycin A1(BafA1) for 24 hours then irradiated with 500J/m2
UVB. Particles were collected 24 hours later. A) shows a representative dot blot of BafA1
and DMSO (vehicle, 0.1%) probed for CPD and ssDNA antibodies. B). NTA analysis of
the particles when normalized to cell counts shows significant increases in BafA1 treated
cells over DMSO controls. A further increase in particle count is not seen after UVB
treatment. Significance was analyzed by a paired 1-way t-test of log (particle counts) to
make the distributions ‘normal’. C) represents CPD, ssDNA and CPD/ssDNA signal of
BafA1 and DMSO control. Significance was analyzed using 1-way ANOVA and Tukey’s
multiple comparison test in GraphPad Prism 8. (*, (p<0.05), **, (0.01<p≤0.01, ***
(0.001<p≤0.001), **** (0.0001<p)

4.6.4 Effect of apoptosis (caspase) inhibitor Z-VAD FMK on CPD release
in exosome fraction from UVB irradiated cells.
Because our results thus far failed to detect a significant role for exosome regulators on
CPD release in SEVs, we next considered that some other cell signaling pathway may be
responsible for promoting CPD release in SEVs from UVB-irradiated HaCaT cells. Cell
death was a pathway of interest. Our time-course data showed that at 24 hours 15% of cells
were dead by trypan blue staining. Additionally, the trends in CPD signal, particle counts,
and trypan blue staining appear to be correlated (Figure 9,10). Therefore, we decided to
examine the effect of compounds that are known to cell death pathways on CPD release in
SEVs.
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The first compound we examined was, Z-VAD FMK, which is a known inhibitor of
caspase mediated apoptosis that also has no measured effect on NER (Kemp et al., 2015).
HaCaT cells were pre-treated with DMSO or 20 µM Z-VAD FMK for 1 hour and then
exposed to 500J/m2. The drug was shown to have the expected result since it decreased the
number of floating apoptotic and pre-apoptotic cells as detected by trypan blue cell counter
assay (Figure 19 A, B). A second routine measure for detecting apoptosis is through
detection of PARP cleavage (Montermini et al., 2015). EV fractions were collected 6 hours
after Z-VAD-FMK treatment and PARP cleavage was reduced in Z-VAD-FMK+UV as
compared to UV+DMSO treated cells (Figure 19). These results indicate that the caspase
inhibitor is showing effects relevant to our experiments at 24 hours and the results can be
seen in EV fractions as well as in cells.
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Figure 19: Cell counts, and abrogated PARP cleavage indicate lower apoptosis in ZVAD-FMK treatment groups.

HaCaT cells were treated either with 10 µL vehicle

(DMSO) or 20 µM Z-VAD-FMK (ZVAD), for 1 hour and then exposed to 500J/m 2 UVB
at 9 J/m2/s. This was performed in 3-5 biological replicates and plots show coordinated
data point colors across all plots. A) Adherent cells removed by trypsinization and B) cells
in pellet 1 of DUC protocol were detected using trypan blue cell counter assay. C)
Adherent and P1 cells were combined to give total cell counts. and show only a significant
drop in cell counts with UVB treatment in the DMSO control. B) Total cells in P1 show a
significant decrease in cells in the Z-VAD FMK+UVB as compared to the DMSO+UVB
control (p<0.05, matched, one-way ANOVA, Tukey’s multiple comparison test), which
increased lower rates of apoptotic death. D). Western Blot of 15% SDS PAGE reducing
gel was probed for PARP in vesicle fractions obtained through differential ultracentrifugation protocol pre-treated with Z-VAD FMK and harvested for 6hr post irradiation
with 500J/m2 UVB or sham treatment. The UVB+Z-VAD-FMK shows a visible drop in
PARP cleavage as compared to the UVB+DMSO control, indicating a reducing in UVB
induced apoptosis. Trends remain after normalization to Ponceau Red protein loading
controls (as shown). (*, (p<0.05), **, (0.01<p≤0.01, *** (0.001<p≤0.001), ****
(0.0001<p)).
Since the caspase inhibitor demonstrated a measurable effect on cell counts at 24
hours after UVB treatment, the levels of DNA content and particle counts in SEV fractions
were measured (Figure 20). As typically seen, the CPD signal increased significantly with
UVB+ treatment as compared to the sham in the DMSO control group (Figure 20).
However, the caspase treatment group did not show significant increase in CPD release
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with UVB treatment. Moreover, ssDNA and CPDs are significantly decreased between ZVAD-FMK+UV versus DMSO+UV groups (*, p<0.5, matched, one-way ANOVA,
Tukey’s multiple comparison test).

Interestingly, this trend was not seen in the

CPD/ssDNA ratios. This may indicate that the pathway regulating the ssDNA and CPD
release in SEVs is the same.
NTA analysis was performed for SEVs in Z-VAD and DMSO samples exposed to UV-B.
Previous reports suggested that caspase inhibitors abrogate particle release due to stress
response like EGFR inhibitors (Ueda et al., 2019a). Significance was analyzed using
matched 1-way ANOVA and Tukey’s multiple comparison test in GraphPad Prism 8. No
significance was seen between any treatment groups, but the UV+Z-VAD-FMK treatment
group had very noisy results.
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Figure 20: Z-VAD FMK blocks the release of SEV-associated CPDs from UVB
irradiated cells. HaCaT cells were treated either with 10 µL vehicle (DMSO) or 20 µM
Z-VAD-FMK (ZVAD), for 1 hour and then exposed to 500J/m 2. This was performed in
3-5 biological replicates and plots show coordinated data point colors across all plots. A)
DNA was isolated and analyzed by immunodot blotting and shows noticeable decrease in
ssDNA and CPD signal with caspase inhibitor. B) Normalized plots show statistically
significant changes in ssDNA and CPD signal with UVB+ caspase inhibitor (*=p<0.05, or
** = 0.0001≤p<0.001, matched, 1-way ANOVA, Tukey’s multiple comparison test) C)
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The particle counts, and particle sizes were analyzed using NTA and show no significant
changes by any statistical test. (*, (p<0.05), **, (0.01<p≤0.01, *** (0.001<p≤0.001), ****
(0.0001<p)).

4.6.5 Effect of necrostatin-1(necroptosis inhibitor) on CPD release in
exosome fraction from UVB irradiated cells.
An additional form of cell death is necroptosis, which is considered a more inflammatory
form of cell death in which cell membranes rupture and cell components leak into the
intracellular space. To determine if CPD presence in SEVs was caused by necroptosis,
HaCaT cells were pre-treated with vehicle (DMSO) or the RIP1 kinase and necroptosis
inhibitor necrostatin-1 and then exposed to UVB. As shown in Figure 22, necrostatin-1
had no significant effect on CPD release from cells.

Figure 21: The necroptosis inhibitor necrostatin-1 does not impact CPD release in
SEVs. HaCaT cells are pre-treated with 10 µM necrostatin, a known necroptosis inhibitor
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or vehicle (DMSO) incubated for 30min and then exposed to UV-B(500J/m2). DNA from
EVs was extracted using DNA isolation kit and EVs were isolated using differential
centrifugation A) dot blot representing the CPD and ss DNA signal in EVs of DMSO and
necrostatin. B) Data depicted as relative CPD signal with DNA. Resulting data is a
collection of 4 independent biological replicate experiments with duplicate samples
normalized to ssDNA signal of DMSO. Significance was analyzed using 1-way ANOVA
and Tukey’s multiple comparison test in GraphPad Prism 8. (*, (p<0.05), **,
(0.01<p≤0.01, *** (0.001<p≤0.001), **** (0.0001<p)).

4.6.6 Effect of spironolactone on the release of CPDs.
To determine if NER plays any role in the release of CPDs in SEVs (Gabbard et al., 2020;
Kemp et al., 2019). HaCaT cells were treated with DMSO or 10µM spironolactone for 2hr
before exposure to UVB. Spironolactone inhibits NER by inducing the rapid proteolytic
degradation of the essential NER protein XPB (Takahashi et al., 2017b)(Ueda et al.,
2019b). Inhibition of XPB shows increased retention of CPDs in SP+UV group when
compared to DMSO+UV after 24 hours post irradiated with UVB (500J/m2) (Figure 23).
Resulting data is a collection of 3 independent biological replicates normalized to ssDNA
signal of DMSO. CPD/ssDNA signal effect is seen in UV+ than in UV- samples.
Spironolactone increased CPD release normally seen with UVB treatment compared to
DMSO group that has shown a significant increase in ssDNA and CPD content upon UVB
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treatment

Figure 22: Effect of spironolactone on CPD and SEV release in HaCaT cells HaCaT
cells are pre-treated with 10µM Spironolactone a known NER inhibitor or vehicle (DMSO)
incubated for 2 hr. and then exposed to UV-B(500J/m2). DNA from EVs was extracted
using DNA isolation kit and EVs were isolated using differential centrifugation: A) Dot
blot representing the CPD and ss DNA signal in EVs of DMSO and Spironolactone. B)
Data depicted as relative CPD signal with DNA.C) Data showing the effect of
spironolactone inhibiting CPD repair. Resulting data is a collection of 3 independent
biological replicate experiments with duplicate samples normalized to ssDNA signal of
DMSO.

Significance

was

analyzed

using

1-way

ANOVA

and

Tukey’s

multiple comparison test in GraphPad Prism 8. (*, (p<0.05), **, (0.01<p≤0.01, ***
(0.001<p≤0.001), **** (0.0001<p)).
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4.7 Determine if CPDs are taken up by other cells.
Biomolecules (DNA, RNA, proteins) associated with EVs can be taken up by cells to
impact cell physiology. To determine if CPDs associated with SEVs can be taken up by
cells, SEVs were isolated by centrifugation from UVB-irradiated HaCaT cells 24 hours
after UVB treatment. 1 10cm dish of EVs was added to a 24-well plate of 90% confluency
naïve, non-irradiated HaCaT cells and incubated for 4 hours. DNA was then purified from
both the cells and remaining cell culture media and analyzed by immune dot blotting. As
shown in Figure.24 (lanes 1-2), approximately 10% of the SEV-associated CPD signal
was found to be present in SEV-treated cells. In contrast, when a similar amount of
genomic DNA purified from UVB-irradiated cells was added to HaCaT cells, very little
CPD signal could be found within the cells (Figure.24, lanes 3-4). The CPD signal instead
remained nearly completely in the cell culture medium. These results indicate that CPD
uptake by cells is greatly enhanced by its association with SEVs.
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Figure 23: SEV associated CPDs can be taken up by non-irradiated cells. SEVs were
isolated from sham or UVB-irradiated cells and then added to the cell culture medium of
naïve, non-irradiated HaCaT cells. Cells were incubated for 4hr, and then DNA was
purified from both the cells and the cell culture medium for analysis of CPD localization
by immune dot blot(lanes1-2). An equivalent amount of genomic DNA (30 ng) purified
from UVB-irradiated HaCaT cells was similarly added to the cell culture medium of naïve
HaCaT cells (lanes 3-4) and processed in a similar manner as for SEV-associated CPDs.
Blots were probed for both CPDs and total DNA. The graph shows the CPD/ssDNA ratio
for the internalized fractions.
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Discussion:
5.1 Summary:
UVB irradiation is a DNA damaging agent and results in the production of
photoproducts in genomic DNA. These are only removed from the genome through
nucleotide excision repair. Yet the DNA containing photoproducts have been found
in the soluble fraction of cells following exposure to high doses of UV exposure that
induce apoptotic caspase signaling (Baek et al., 2018b). Moreover, we have
demonstrated that these photoproducts are found outside of the cell in several
extracellular fractions. As the fate of these adducts remains unknown, studying of
release of photoproducts is important for the better understanding of diseases
associated with UVB exposure.
Extracellular vesicles have been demonstrated to contain DNA and damaged DNA
(Lázaro-Ibáñez et al., 2019a; Torralba et al., 2018b; Tucher et al., 2018; Xu et al.,
2018). However, the mechanism of loading of DNA into extracellular vesicles is still
relatively unknown. This current study was designed to investigate the quantities and
locations of extracellular CPD adducts containing DNA and the export method of
these CPDs to extracellular fractions. This work shows that bulky DNA adducts
(CPDs) are associated with SEVs released from keratinocytes in a caspase dependent
pathway. We also showed that the SEV associated DNA has increased internalization
efficiency into adjacent cells. We believe that bulky DNA adducts can be taken as a
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factor to trace DNA and this may even help in better understanding of DNA EV
pathways.
For this study we used human immortalized keratinocytes (HaCaT). First, to
characterize the properties of CPD and DNA release from cells in SEV fractions, fractions
isolated by DUC (Figure 5) were analyzed. We were able to identify CPD containing DNA
in the SEV and AB fractions but not in LEV fraction upon UVB exposure (Figure 7). We
quantified the CPDs present in SEV fraction and observed that CPDs in total media fraction
is less than 1% of the total CPDs that were induced by UVB exposure. The DUC separation
protocol was further analyzed to confirm vesicle identities by performing western blot of
different fractions isolated through DUC. Canonical proteins for each vesicle were detected
in each DUC fraction. As expected, DUC at 2000xg isolated calreticulin positive vesicles,
20,000xg spins isolated ARF6 positive LEVs, and 170,000xg spins isolated tetraspanin
positive SEVs. This implies that these fractions contain apoptotic bodies, MVPs, and
exosomes, respectively. Interestingly, UVB did have an effect on some canonical markers.
UVB did reduce content of canonical SEV proteins, which may indicate an increase in
alternate vesicle biogenesis pathway upon UVB irradiation.
Also, we found that the DNA in EVs may be chromosomal due to the presence of histones.
Histones and other DNA bound proteins like PCNA were observed in UV irradiated SEV
samples. Moreover, we observed histones namely H2AX, H3 enriched in UVB treated SEV
fraction when compared to LEV fraction which confirms the presence of DNA in SEVs
(Sansone et al., 2017).
There is some debate as to whether DNA is luminal or external to SEVs. Therefore,
localization of DNA was studied. Results show that DNA present on SEVs was surface
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associated as it was susceptible to the digestion by DNase. We further analyzed the size of
DNA present in SEVs and observed large size of DNA upon UVB exposure. We believe
that the large size was due to the presence of DNA lesions that inhibit the degradation by
cellular nucleases (Kemp et al., 2015).
To further investigate CPD and DNA release, UVB dose dependence and
kinetics of photoproduct release was performed. This work showed that CPDs are released
from cells in SEV fractions in a UVB dose dependent manner, but that DNA content was
not dramatically affected by UVB. Additionally, CPDs were released as early as 0hrs after
the exposure. But showed significant increase after 6hours and later which provides the
evidence that repair of small fragments occurs through NER at earlier time points whereas
higher time points contain larger fragments of DNA. These small fragments were reported
to be present in the soluble fraction of photoproduct containing DNAs that follow caspase
regulated pathway (Baek et al., 2018b).
According to Aim 2 we wanted to understand which regulated pathway is involved
in trafficking of CPD containing DNA into SEV fractions. Pharmacological modulation of
EV release pathways and other DNA damage response pathways were studied. Exosome
modulators like D609 and GW4869 did not alter the presence of CPDs in SEVs, which
suggests that the CPD-containing SEVs are not released by the ceramide pathway.
Furthermore, lysosome inhibitors like hydroxy chloroquine or Bafilomycin A1 typically
cause an increase in vesicle biogenesis by disrupting autophagic degradation of endosomal
content (Ortega et al., 2019). In preliminary screenings, CQ also did not significantly affect
CPD release, but we do not know that the drug had an effect. A related drug, bafilomycin
A1 also did not show an effect on CPD or ssDNA release but did show NTA particle count
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changes. This suggests that the endo lysosomal pathway is not the major regulator of CPDDNA content release.
Since cell death as measured by trypan blue staining showed correlation with
vesicle counts and CPD content, we switched to focus on cell death pathway modulators.
We used necrostatin-1, which inhibits necroptosis by inhibiting RIP1 kinase. We expect to
see an inhibitory effect on CPD release, but we observed no significant effect. Lastly, we
tried to investigate whether apoptotic pathways may be involved in the export of CPDs.
We used Z-VAD FMK, a pan-caspase inhibitor that inhibits caspase mediated apoptotic
pathway. Treatment with 20 µM Z-VAD-FMK resulted in a significant decrease in the
CPD signal when compared to the sham group. This is interesting because it may indicate
that a pathway involved in apoptosis is involved. Moreover, inhibition of caspase 3
signaling can prevent apoptotic vesicle biogenesis (Yingying Zhang et al., 2018). We did
not see significant reduction in vesicle release, but the NTA analysis was very noisy.
Future work may clarify this relationship. Additionally, Z-VAD-FMK is pan-caspase
inhibitor. Further work could be done to isolate which caspase is most relevant to inhibiting
release of CPD containing DNA.
Lastly, we hypothesized that DNA damage response may also play a role in recognition of
CPDs in DNA and subsequent export. We used NER inhibitor, spironolactone, to deplete
a component of TFIIH complex, XPB and saw the expected increased persistence of CPDs
in the genomic DNA (Figure 23C). However, no significant changes in CPD or DNA
content in SEVs were seen. Moreover, no changes in vesicle release were seen. This may
indicate that NER is not involved in recognition of the DNA damage for export in SEV
fractions.
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Studies have shown that cell physiology may be altered by the uptake of RNA,
micro-RNA, DNA of other cells. Previous studies have indeed shown that EV-associated
DNA may be taken up by bystander cells and impact cell function and survival (Cai et al.,
2013; Kitai et al., 2017c)(Fischer et al., 2016; Torralba et al., 2018a) (Riley & Tait, 2020b).We
also saw increased uptake of CPDs in the DNA when the DNA was SEV associated
compared to that of genomic DNA. Thus, we believe that the uptake of SEVs containing
CPDs may impact target cell physiology by activating DNA damage responses and or the
cGAS/STING pathway of the innate immune response

5.2 Limitations and Future Directions:
Despite showing the presence of CPDs in SEVs and possible EV pathways that are
involved, precisely how the adducts get exported through SEVs remain to be determined.
Confirmation of pathways will require the targeting of specific caspases through a
combination of pharmacological and genetic approaches. A limitation of this study was
that it will be difficult to confirm that only SEVs were involved in the export of bulky DNA
adducts. In future work, it will be important to translate these in vitro findings to human
and/or mouse skin ex vivo and in vivo. We expect to see similar results as that of cells but
there may be higher threshold of dose and time dependent release of bulky adducts in skin.
Further observance of uptake of EVs will help to study SEV mediated DNA inflammatory
responses in different cell lines.
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5.3 Conclusion:

These studies provide promising evidence that CPDs that are generated after UVB
exposure could be taken up by EVs. Thus, these studies suggest the possible involvement
of EVs in the UVB associated DNA damage by the characterization of the mechanisms of
EV pathways. An improved understanding of the exact role of EVs in the uptake of DNA
containing CPDs can result in the development of DNA EV packaging models. Thus, EVs
can be taken as the predictors of UVB associated DNA damage. Further studies are
involved to determine whether other environmental genotoxins and anti-cancer drugs
similarly impact SEV associated DNA. Thus, properties of SEV could be explored and
function of SEV could be investigated by the contribution of DNA lesions. These studies
are expected to show a positive impact and to advance our understanding of how DNA
damaging agents have systemic effects throughout our body.
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